Development of adenovirus type 11 (Ad11) as a platform for immuno-oncology applications

Project Code

MRCIIAR24Ca Parker

Research Theme

Infection, Immunity, Antimicrobial Resistance and Repair

Full Project Description

Please download the below document for a full project description and to see the full supervisory team.


Adenoviruses (Ad) are important for both vaccine and oncology applications, exemplified by their widespread use during the COVID pandemic. This project will characterise and develop a new platform, Ad11 for vaccine and targeted gene therapy/virotherapy applications. Building on preliminary studies, this studentship will include vector development, basic structural biology and transcriptomic studies to assess the therapeutic potential of Ad11.

Lead Supervisor

Professor Alan Parker

Lead Supervisor Email

University Affiliation